CML66 inhibitors are a class of chemical compounds primarily recognized for their ability to modulate the activity of the CML66 protein, a target identified in various cellular processes. The CML66 protein is involved in pathways that are critical for cellular growth, differentiation, and signaling. Inhibitors of CML66 are characterized by their structural diversity, often possessing unique molecular frameworks that allow for specific binding to the active or regulatory sites of the CML66 protein. These inhibitors typically include small organic molecules that have been designed or identified through high-throughput screening processes and rational drug design. The primary mechanism of action for these inhibitors involves the interruption of protein-protein interactions or the direct binding to the enzymatic pocket, which in turn alters the conformational state of the CML66 protein. This inhibition can lead to downstream effects on cellular pathways, such as altered signal transduction or changes in gene expression, highlighting the role of CML66 as a pivotal control point in various biological contexts.
From a chemical perspective, CML66 inhibitors can be categorized based on their core structural motifs, such as heterocyclic scaffolds, aromatic rings, or peptidomimetic backbones. The binding affinity and selectivity of these inhibitors are often modulated by the presence of various functional groups, including hydroxyls, amines, and carboxylates, which interact with the specific amino acid residues of the CML66 protein. Additionally, modifications like fluorination or alkylation are employed to enhance the metabolic stability and solubility of these compounds. Researchers have developed several classes of these inhibitors, including reversible and irreversible binders, each tailored to target different aspects of the CML66 protein's functionality. Advances in computational chemistry, such as molecular docking and dynamics simulations, have significantly contributed to the understanding of how these inhibitors interact at the molecular level, guiding the optimization of their chemical properties to enhance their potency and specificity. These efforts underscore the significance of CML66 inhibitors as versatile tools for dissecting the complex biology associated with the CML66 protein and for exploring its broader implications in cellular function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and could prevent NUDCD1 from exerting its effect on microtubule dynamics. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule assembly, potentially counteracting NUDCD1-associated microtubule functions. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that could negate the stabilizing influence of NUDCD1 on microtubules. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin and may inhibit the potential role of NUDCD1 in microtubule organization. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Inhibits tubulin polymerization and could interfere with NUDCD1-related microtubule functions. | ||||||
Eribulin | 253128-41-5 | sc-507547 | 5 mg | $865.00 | ||
Inhibits the growth phase of microtubule dynamics, potentially impacting NUDCD1's role. | ||||||